1-9 of 9
Daniel Ahn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract OT2-11-01: A phase 1 study of the novel immunotoxin MT-5111 in patients with HER2+ tumors: interim results

Meena Okera, Brian A. Van Tine, Joleen M. Hubbard, Minal Barve, Erika Hamilton, Monica M. Mita, Frances Valdes-Albini, Daniel Ahn, Admasu Mamuye, Joshua Pelham, Amy Yuet, Diana Yurewicz, Yanning Liu, Andres Machado Sandri, William J. Edenfield, Aki Morikawa, William Gradishar, Rajiv Kumar, Zev A. Wainberg
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT2-11-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT2-11-01
Published: 01 March 2023
View article titled, Abstract OT2-11-01: A phase 1 study of the novel immunotoxin MT-5111 in patients with HER2+ tumors: interim results
Journal Articles

Abstract 6274: Prognostic impact of Sarcopenia on clinical outcomes in advanced hepatocellular carcinoma (HCC) treated with systemic therapy

Gehan Botrus, Pedro Luiz Serrano Uson Junior, Heidi Kosiorek, Mehmet Akce, Isabela Chang, Zhubene Mesbah, Eric Yancey, Daniel Blezek, Jason Klug, Lana Khalil, Puneet Raman, Mohamad Sonbol, Mitesh Borad, Daniel Ahn, Tanios Bekaii-Saab
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6274.
https://doi.org/10.1158/1538-7445.AM2022-6274
Published: 15 June 2022
View article titled, Abstract 6274: Prognostic impact of Sarcopenia on clinical outcomes in advanced hepatocellular carcinoma (HCC) treated with systemic therapy
Journal Articles

Abstract P2-13-45: Interim results of a phase 1 study of the novel immunotoxin MT-5111 in patients with HER2+tumors

Brian A. Van Tine, Monica Mita, Minal A. Barve, Erika P. Hamilton, Andrew J. Brenner, Frances Valdes, Daniel Ahn, Joleen Hubbard, Jason Starr, Angela Georgy, Joshua Pelham, Banmeet S. Anand, Thomas Strack, Andrés Machado Sandri, Zev A. Wainberg
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-13-45.
https://doi.org/10.1158/1538-7445.SABCS21-P2-13-45
Published: 15 February 2022
View article titled, Abstract P2-13-45: Interim results of a phase 1 study of the novel immunotoxin MT-5111 in patients with HER2+tumors
Journal Articles

Abstract CT010: Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements

Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Chigusa Morizane, Juan W. Valle, Thomas B. Karasic, Thomas A. Abrams, Robin Kate Kelley, Philippe Cassier, Junji Furuse, Heinz-Josef Klümpen, Heung-Moon Chang, Li-Tzong Chen, Yoshito Komatsu, Kunihiro Masuda, Daniel Ahn, Yaohua He, Nital Soni, Karim A. Benhadji, John A. Bridgewater
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT010.
https://doi.org/10.1158/1538-7445.AM2021-CT010
Published: 01 July 2021
View article titled, Abstract CT010: Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
Journal Articles

Abstract CT130: Phase 1 study of the novel immunotoxin MT-5111 in patients with HER-2+tumors

Zev A. Wainberg, Monica M. Mita, Minal A. Barve, Erika P. Hamilton, Andrew J. Brenner, Frances Valdes, Daniel Ahn, Joleen Hubbard, Jason Starr, Christine Burnett, Joshua Pelham, Eric T. Williams, Banmeet S. Anand, Thomas Strack, Andrés Machado Sandri, Brian A. Van Tine
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT130.
https://doi.org/10.1158/1538-7445.AM2021-CT130
Published: 01 July 2021
View article titled, Abstract CT130: Phase 1 study of the novel immunotoxin MT-5111 in patients with HER-2+tumors
Journal Articles

Abstract LB-235: COLOMATE: Colorectal cancer and liquid biopsy screening protocol for molecularly assigned therapy

Kristen K. Ciombor, Fang-Shu Ou, Andrew Dodge, Tyler Zemla, Christina Wu, Kimmie Ng, Katrina Pedersen, Shumei Kato, Pashtoon M. Kasi, Daniel Ahn, Rebecca Nagy, Richard Lanman, Scott Kopetz, John H. Strickler, Tanios Bekaii-Saab
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-235.
https://doi.org/10.1158/1538-7445.AM2019-LB-235
Published: 01 July 2019
View article titled, Abstract LB-235: COLOMATE: Colorectal cancer and liquid biopsy screening protocol for molecularly assigned therapy
Journal Articles

Abstract CT017: A Phase Ib of a combination of two chimeric (Trastuzumab-like and Pertuzumab-like) HER-2 B cell peptide vaccine emulsified in ISA 720 and nor-MDP adjuvant in patients with advanced solid tumors

Tanios Bekaii-Saab, Lai Wei, Robert Wesolowski, Daniel Ahn, Christina Wu, Maryam Lustberg, Amir Mortazavi, Bhuvaneswari Ramaswamy, Jay Overholser, Pravin Kaumaya
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT017.
https://doi.org/10.1158/1538-7445.AM2019-CT017
Published: 01 July 2019
View article titled, Abstract CT017: A Phase Ib of a combination of two chimeric (Trastuzumab-like and Pertuzumab-like) HER-2 B cell peptide vaccine emulsified in ISA 720 and nor-MDP adjuvant in patients with advanced solid tumors
Journal Articles

Mice Deficient for N- ras : Impaired Antiviral Immune Response and T-Cell Function

Ignacio Pérez de Castro, Roberto Diaz, Marcos Malumbres, María-Inmaculada Hernández, Jaishree Jagirdar, María Jiménez, Daniel Ahn, Angel Pellicer
Journal: Cancer Research
Cancer Res (2003) 63 (7): 1615–1622.
Published: 01 April 2003
View article titled, Mice Deficient for N- <em>ras</em> : <subtitle>Impaired Antiviral Immune Response and T-Cell Function</subtitle>
Open the PDF for Mice Deficient for N- <em>ras</em> : <subtitle>Impaired Antiviral Immune Response and T-Cell Function</subtitle> in another window
Journal Articles

The N- ras Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene

Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, Marcos Malumbres, Ignacio Perez de Castro, Jeffrey Lue, Neus Ferrer-Miralles, Ramon Mangues, Jerry Tsong, Roberto Garcia, Roman Perez-Soler, Angel Pellicer
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4514–4518.
Published: 01 August 2002
View article titled, The N- <em>ras</em> Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene
Open the PDF for The N- <em>ras</em> Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene in another window